Zydus Cadila receives FDA blessing for generic Renvela

Press enter to search
Close search
Open Menu

Zydus Cadila receives FDA blessing for generic Renvela

By Sandra Levy - 09/01/2020

The Food and Drug Administration has granted clearance to Zydus Cadila for sevelamer carbonate tablets in a dosage strength of 800 mg.

The product is the generic of Sanofi-Aventis' Renvela and is indicated to for use by patients with chronic kidney disease who are on dialysis to control their phosphorus levels.

The drug is a phosphate binder that helps prevent hypocalcemia (low levels of calcium in the body) caused by elevated phosphorus.

It will be manufactured at the group’s formulation manufacturing facility at SEZ, Ahmedabad.

Related Topics